Home/ Stocks/ CRVO

CervoMed Inc. Common Stock

CRVO XNAS

$4.72 +2.23 (+89.92%) ▲ 15-min delayed

Open

$3.34

High

$7.45

Low

$2.99

Volume

192.47M

Market Cap

$22.96M

About CervoMed Inc. Common Stock

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 15 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-7,964,158	$-0.86
FY 2025	$4.01M	$-26,966,367	$-2.98
Q3 2025	$322.6K	$-7,726,639	$-0.84
Q2 2025	$1.76M	$-6,258,404	$-0.70

Earnings & Analyst Ratings

Next Earnings: Thu, Aug 6, 2026

Calendar →

TickerDaily Coverage

Why Is CervoMed Inc. Common Stock (CRVO) Stock Up 50.0% Today?

Penny Stocks Marcus Rivera · 4h ago

CervoMed Inc. Common Stock (CRVO) exploded 50% to $3.8319 on massive volume after its neflamapimod...

View All Coverage →

Get CRVO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on CervoMed Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.